Cardiac Mapping Market Overview
New entrants into the market, increased investments, funding, and grants, increasing incidence of target diseases, and growth in the geriatric population are all driving factors in the cardiac mapping industry's growth. Increased funding and grants for research and development efforts in cardiac mapping technology, rising prevalence of target diseases, and a growing geriatric population are all major drivers propelling the Cardiac Mapping Market forward. The rise in the incidence of cardiovascular diseases among all age groups as a result of a sedentary lifestyle and obesity, as well as the involvement of key companies such as Abbott and Medtronic in the manufacturing of contact mapping systems, are expected to boost the market's growth during the forecast period.
In the last ten years, interventional electrophysiology has advanced dramatically. Cardiac mapping is one of the most sophisticated methods for collecting and displaying information from an ECG. It's defined as a method for determining the spatial and temporal distribution of cardiac electrical signals during a specific heart beat. The data is sent to the software, which creates a three-dimensional (3D) model of the heart, displaying the electromagnetic waves generated during each beating. The approach reveals the catheter's position and movement inside the heart. Cardiac mapping is a simple process that allows doctors to locate the location of heart chambers that are suffering arrhythmia. The cardiac mapping market is expected to reach USD 1179.81 Million by 2030 at 8.20% CAGR during the forecast period 2022-2030.
Several advanced diagnostic technologies introduced by medical device companies, increased demand for precise diagnosis of critical cardiac diseases, and the availability of well-qualified interventional cardiologists in developed economies are expected to boost the growth of the cardiac mapping systems market over the forecast period.
However, in the near future, lack of awareness about cardiac mapping systems in underdeveloped countries, their high cost, and the risks associated with cardiac mapping procedures are expected to be major restraints of the cardiac mapping systems market. Furthermore, due to macroeconomic disruptions caused by the COVID-19 pandemic, there will be significant changes in the product pipeline and entire supply chain. As a result of the eruption, government officials are increasingly concerned about residents' and healthcare personnel' health and safety. Furthermore, several regulatory agencies and governments have created a slew of different safety requirements. When COVID-19 cases start to decline, other chronic diseases will once again become a priority. These reasons suggest that the cardiac mapping market will continue to grow in the future.
Regional Overview
In terms of regions, cardiac mapping is expected to be the most popular during the projected period in North America. The major factors driving the North American market are an increase in the approval rate of mapping systems and clinical trials validating cardiac mapping systems in the United States, a high incidence of CVDs, a growing focus of government organizations on providing funding for research, and an increasing geriatric population in Canada. The market will be driven by the flexible management of patients in US hospitals and attractive reimbursement policies for cardiovascular disorders. Because of the integration of technology and health care in North American health care facilities, the area is likely to remain dominating during the projected period.
During the projection period, Europe and Asia-Pacific are also likely to provide profitable prospects. In India and Australia, the number of interventional cardiologists is expanding, raising knowledge of cardiac mapping devices in those nations. This is thought to be a key element in the market's projected expansion in Asia Pacific at a comparatively high CAGR during the forecast period.
Competitive Dynamics
Cardiac Mapping Market players are Abbott Laboratories, GE Healthcare, Boston Scientific Corporation, Medtronic plc., Johnson & Johnson, Koninklijke Philips N.V., Hill-Rom Services, Inc., and others.
Market Segmentation
The Global Cardiac Mapping Market is divided into three categories: product, indication, and end user.
The market has been segmented into two categories based on product: contact cardiac mapping systems and non-contact cardiac mapping systems. Because of its widespread availability, contact cardiac mapping devices are expected to have the largest market share in the worldwide cardiac mapping industry.
Atrial fibrillation, atrial flutter, atrioventricular nodal reentrant tachycardia (AVNRT), Wolff-Parkinson-White Syndrome (WPW), and other indications have been divided into the cardiac mapping market. Because of the significant number of individuals who suffer from atrial fibrillation, the sector is expected to have the biggest market share.
Hospitals, clinics, diagnostic centers, and others are among the end user categories of market. As these are the principal places where patients obtain diagnosis and treatment, hospitals are likely to hold the highest share of the market. Due to the high frequency of cardiac arrhythmias and the growing awareness of them in emerging nations, the segment is likely to continue its leadership position during the projected period.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
